To explain whether the genetic variants of CDKN1B and CCND2 found here to be associated with a different clinical course of CLL might affect the protein expression of these cell cycle regulators, we performed functional studies. Here, CDKN1B is linked to B-cell chronic lymphocytic leukemia.